Active, not recruitingNCT07096206
Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International Study
Studying Ectodermal dysplasia syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Pierre Fabre Medicament
- Principal Investigator
- Marlène GuiraudPierre Fabre Médicament
- Enrollment
- 27 enrolled
- Eligibility
- 0-11 years · MALE
- Timeline
- 2023 – 2026
Study locations (2)
- Necker hospital, Paris, France
- Uniklinikum Erlangen, Erlangen, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07096206 on ClinicalTrials.govOther trials for Ectodermal dysplasia syndrome
Additional recruiting or active studies for the same condition.